13.04.2013 Views

Funding

Funding

Funding

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

30<br />

<strong>Funding</strong> initiative<br />

“Lichtenberg Professorships”<br />

– see page 66<br />

“Soft matter” is the central topic, even on the<br />

staircase: (from the left) Kerstin Schindler<br />

(chemist), Heiko Schoberth (physicist), Petra<br />

Zippelius, Anne Horn (chemist), Dr. Li-Tang<br />

Yan, Dr. Sujit Kumar Gosh and Gonther Jutz<br />

(chemist) make up the team around Professor<br />

Dr. Alexander Böker (foreground).<br />

By means of his fine synthetic membranes with nanopores of a defined size,<br />

he is pursuing the goal of producing tiny containers, vehicles in which cells<br />

or medicaments can be encapsulated. One concrete application he is working<br />

on – together with cooperation partners – is the treatment of the autoimmune<br />

disease type I diabetes mellitus. This disease occurs in diabetics, when the<br />

sick person’s own immune system attacks and destroys cells that produce the<br />

vital insulin. If Alexander Böker is successful in shutting insulin-producing<br />

cells in his revolutionary capsules, these can then be embedded into the patient’s<br />

pancreas, where they can then discharge their contents. “The size of the pores<br />

in the membranes we are experimenting with can be defined so exactly that<br />

the attacking cells released by the patient’s immune system cannot get through<br />

– thus shielding the process of insulin production.” This could lead to a cure<br />

for diabetics.<br />

The researcher intends to encapsulate not only cells but also drugs. It would be<br />

most unlike a Lichtenberg Professor to stop at only one application for a new<br />

discovery. No, his capsules must also be capable of being “activated”. Encapsulated<br />

in his new membranes, he also wants to transport drugs – against cancer<br />

for instance. And these should not be released until once inside the tumor.<br />

How does he intend to achieve this? Alexander Böker is in his element as he<br />

explains how he wants to design his pores to have functions, e.g. to open up<br />

like an automatic door when activated by an external chemical signal. In certain<br />

types of tumor, it might be possible to trigger such a function by means<br />

of a very slight shift in the acidity level within the tissue: This would cause<br />

the chemical barriers in the pores to contract, forming a sort of spiral, and<br />

thereby opening the container. Vision? Yes – but a rather plausible one.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!